Yale spinout Halda founded by Craig Crews raises $126M to advance 'hold and kill' solid tumor drugs into the clinic
Halda Therapeutics Secures $126 Million Financing to Advance RIPTAC™ Cancer Therapies into the Clinic for Major Solid Tumors
